Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1983]
News [3217]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
ASH 2019: New drug markedly improves overall survival in patients with AML in remission
ASH 2019: New drug markedly improves overall survival in patients with AML in remission
ASH 2019: Study reveals genetic underpinnings of AML and myelodysplastic syndrome
ASH 2019: Study reveals genetic underpinnings of AML and myelodysplastic syndrome
ASH 2019: Triple drug combination delays disease progression in people with stubborn multiple myeloma
ASH 2019: Triple drug combination delays disease progression in people with stubborn multiple myeloma
ASH 2019: Immunotherapy superior to chemotherapy for children with relapsed B-ALL
ASH 2019: Immunotherapy superior to chemotherapy for children with relapsed B-ALL
ASH 2019: Daratumumab shows overall survival benefit and continued improvement in progression-free survival in patients with newly diagnosed multiple myeloma who are ineligible for transplant
ASH 2019: Daratumumab shows overall survival benefit and continued improvement in progression-free survival in...
ASH 2019: Combination therapy aimed at slowing the progression of a precursor myeloma condition
ASH 2019: Combination therapy aimed at slowing the progression of a precursor myeloma condition
ASH 2019: Novel immunotherapy agent for multiple myeloma shows promising pre-clinical results
ASH 2019: Novel immunotherapy agent for multiple myeloma shows promising pre-clinical results
ASH 2019: Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic Hodgkin lymphoma
ASH 2019: Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic...
ASH 2019: CAR-T immunotherapy shows success and reduces health care utilisation in older patients
ASH 2019: CAR-T immunotherapy shows success and reduces health care utilisation in older patients
ASH 2019: Genomic features of AML in patients over age 60 can predict success of bone marrow stem cell transplant
ASH 2019: Genomic features of AML in patients over age 60 can predict success of bone marrow stem cell transplant

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation